Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

FUPBY vs. HWKN: Which Stock Is the Better Value Option?
FUPBY vs. HWKN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either FUCHS SE - Unsponsored ADR (FUPBY) or Hawkins (HWKN). But which of these two companies is the best

Here's Why You Should Retain Accenture Stock in Your Portfolio Now
Here's Why You Should Retain Accenture Stock in Your Portfolio Now

Shares of Accenture plc ACN have had a decent run over the past month. The stock has risen 1.2% compared with the industry's 1.9% growth. The Zacks S&P 500 composite declined 0.8% during the said

Can KLA Outgrow Chip Equipment Market Through 2030?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
Can KLA Outgrow Chip Equipment Market Through 2030?

KLA Corporation KLAC is strengthening its position in the chip equipment market as AI-driven semiconductor complexity makes process control increasingly critical to advanced manufacturing. The

RH Set to Report Q1 Earnings: What Should Investors Expect?
RH Set to Report Q1 Earnings: What Should Investors Expect?

RH RH is scheduled to report its first-quarter fiscal 2026 (ended May 2, 2026) results on June 11, after the closing bell.In the last reported quarter, the company’s adjusted earnings per share of

3 U.S. Integrated Energy Stocks Poised to Weather Industry ChallengesPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
3 U.S. Integrated Energy Stocks Poised to Weather Industry Challenges
The high crude prices, although favorable for upstream operations, have been severely hurting the integrated energy company’s refining operations. The slowdown in production growth of crude oil will
Can Verizon's Fiber Expansion Strategy Benefit From Rising AI Demand?Photo, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Can Verizon's Fiber Expansion Strategy Benefit From Rising AI Demand?

Verizon Communications Inc. VZ is expanding its fiber network to meet growing demand for high-speed Internet, cloud services and artificial Intelligence (AI)-driven data traffic. The acquisition of

BXP Stock Gains 20.7% in Three Months: Will the Momentum Last?
BXP Stock Gains 20.7% in Three Months: Will the Momentum Last?

Shares of BXP Inc. BXP have gained 20.7% over the past three months, outperforming the industry's growth of 4.1%.

BXP’s gateway portfolio of premier workplaces continues to draw tenants that value

Can Corning's Multibillion-Dollar AI Deal With Amazon Lift Its Shares?Photo, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
Can Corning's Multibillion-Dollar AI Deal With Amazon Lift Its Shares?

Corning Incorporated GLW has signed a multibillion-dollar, long-term agreement with Amazon.com, Inc. AMZN to supply optical fiber, cable and connectivity solutions for Amazon's growing U.S. data

Smucker Q4 Earnings Beat Estimates, Sales Miss on Volume Dip
Smucker Q4 Earnings Beat Estimates, Sales Miss on Volume Dip

The J. M. Smucker Company SJM reported fourth-quarter fiscal 2026 results, wherein earnings surpassed the Zacks Consensus Estimate, while net sales missed the same. The company delivered

J&J to Expand Cancer Pipeline With $1B Firefly Bio AcquisitionPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
J&J to Expand Cancer Pipeline With $1B Firefly Bio Acquisition

Johnson & Johnson JNJ announced that it has entered into a definitive agreement to acquire California-based biotech, Firefly Bio, for $1 billion in cash.

The impending acquisition will add Firefly

Insider Watch: CEOs Are Buying These 3 Stocks
Insider Watch: CEOs Are Buying These 3 Stocks

Investors closely monitor insider buys, as they can often be a decent gauge of sentiment regarding a stock's long-term outlook.

But it’s critical to note that insiders have longer holding periods

Best Momentum Stocks to Buy for June 9thPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Best Momentum Stocks to Buy for June 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 9:

XPO, Inc. XPO: This freight transportation company has a Zacks Rank #1 and witnessed

NOK Benefits From Strong Growth in AI Revenues: More Upside Ahead?Photo, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
NOK Benefits From Strong Growth in AI Revenues: More Upside Ahead?

Nokia Corporation NOK is increasingly emerging as an AI infrastructure beneficiary rather than a traditional telecom-equipment vendor. The company's AI & Cloud revenues jumped 49% in the first

Reasons Why You Should Hold ABM Stock in Your Portfolio
Reasons Why You Should Hold ABM Stock in Your Portfolio

Shares of ABM ABM have had a decent run over the past month. The stock has risen 7.7% against the industry's 0.9% decline. The Zacks S&P 500 composite fell 0.8% during the said time frame.

ABM has a

ANET Gains From Robust Liquidity: Will the Trend Persist?
ANET Gains From Robust Liquidity: Will the Trend Persist?

Arista Networks, Inc. ANET ended the first quarter of fiscal 2026 with $2.79 billion in cash and cash equivalents and approximately $12.35 billion in cash, cash equivalents and marketable

Will Oracle's AI Infrastructure Momentum Drive Results in Q4?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7835e381-fcae-4834-ba93-4708292dc055.png
Will Oracle's AI Infrastructure Momentum Drive Results in Q4?

Oracle Corporation ORCL is set to report fourth-quarter fiscal 2026 results on June 10, 2026. (Read More: Should You Buy, Sell or Hold Oracle Stock Before Q4 Earnings?)Heading into the print

Can Shopify's Strong Execution Outweigh Valuation Concerns in H2 2026?
Can Shopify's Strong Execution Outweigh Valuation Concerns in H2 2026?

Shopify Inc. SHOP enters the second half of 2026 with a valuation that leaves little room for disappointment. The stock currently trades at a forward 12-month price-to-sales (P/S) ratio of 8.9x

Vail Resorts Q3 Earnings Miss Estimates on Unfavorable Weather
Vail Resorts Q3 Earnings Miss Estimates on Unfavorable Weather

Vail Resorts, Inc. MTN posted third-quarter fiscal 2026 results, with earnings per share (EPS) missing the Zacks Consensus Estimate and revenues meeting the same. On a year-over-year basis, both the

Microchip or Fabrinet: Which Tech Stock Is a Better Buy Now?
Microchip or Fabrinet: Which Tech Stock Is a Better Buy Now?

Two companies currently drawing significant investor interest in the   Zacks Computer and Technology sector are Microchip Technology MCHP and Fabrinet FN.

Microchip Technology develops, manufactures

Block Expands Afterpay and Cash App Pay Across New Brands
Block Expands Afterpay and Cash App Pay Across New Brands

Block’s XYZ Cash App has expanded the reach of its commerce payment solutions, Afterpay and Cash App Pay, by adding several new merchant partners. The move aims to provide consumers with greater

JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?

Johnson & Johnson JNJ and AstraZeneca AZN are among the largest global drugmakers, each supported by a diversified healthcare business. Both maintain a significant footprint in oncology. Beyond

Mastercard Down 15% YTD Despite Strong Operations: Buy, Hold or Sell?
Mastercard Down 15% YTD Despite Strong Operations: Buy, Hold or Sell?

Year to date, Mastercard Incorporated MA shares have declined 14.9%, trailing rival Visa Inc. V, which is down 8.9%, while American Express Company AXP has lost 15.6%. The broader industry dropped

AMZN Intensifies AI Push With Latest Warehouse Robots: What's Ahead?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
AMZN Intensifies AI Push With Latest Warehouse Robots: What's Ahead?

Amazon AMZN is doubling down on artificial intelligence within its fulfillment operations, unveiling a new generation of AI-powered warehouse robots that signal a significant shift in how the

Beyond SpaceX: ETFs That Can Help to Tap the Growing Space Economy
Beyond SpaceX: ETFs That Can Help to Tap the Growing Space Economy

The excitement surrounding a potential SpaceX IPO has helped reignite investor interest in the space economy, but the investment opportunity extends far beyond it. The space economy is rapidly

PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi
PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi

Pfizer PFE announced that the FDA has approved its anti-TFPI inhibitor Hympavzi (marstacimab) for the treatment of two additional hemophilia A or B patient populations. The latest approval now